Although the exact mechanism by which CA-4 reduces ROS in stimulated lymphocytes remains to be fully elucidated, the differential effects observed between healthy and tumor cells strongly support the selective antitumor activity of the compound. This evidence concerns the gene CA4 and neoplasm.